This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 May 8;397(10286):1689-1691.

doi: 10.1016/S0140-6736(21)00709-1. Epub 2021 Mar 25.

COVID-19 vaccines for the European region: an unprecedented challenge

Hans Kluge¹, Martin McKee²

Affiliations

Affiliations

¹ WHO Regional Office for Europe, DK-2100 Copenhagen, Denmark.
² Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London WC1H 9SH, UK. Electronic address: martin.mckee@lshtm.ac.uk.

PMID: 33773611
PMCID: PMC7993924
DOI: 10.1016/S0140-6736(21)00709-1

COVID-19 vaccines for the European region: an unprecedented challenge

Hans Kluge et al. Lancet. 2021.

. 2021 May 8;397(10286):1689-1691.

doi: 10.1016/S0140-6736(21)00709-1. Epub 2021 Mar 25.

Authors

Hans Kluge¹, Martin McKee²

Affiliations

¹ WHO Regional Office for Europe, DK-2100 Copenhagen, Denmark.
² Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London WC1H 9SH, UK. Electronic address: martin.mckee@lshtm.ac.uk.

PMID: 33773611
PMCID: PMC7993924
DOI: 10.1016/S0140-6736(21)00709-1

No abstract available

PubMed Disclaimer

Figures

None

See this image and copyright information in PMC

Similar articles

COVID-19 vaccine mandates in Europe.
Burki T. Burki T. Lancet Infect Dis. 2022 Jan;22(1):27-28. doi: 10.1016/S1473-3099(21)00776-3. Lancet Infect Dis. 2022. PMID: 34953554 Free PMC article. No abstract available.
COVID-19 in Europe: new challenges for addressing vaccine hesitancy.
Karafillakis E, Van Damme P, Hendrickx G, Larson HJ. Karafillakis E, et al. Lancet. 2022 Feb 19;399(10326):699-701. doi: 10.1016/S0140-6736(22)00150-7. Epub 2022 Feb 3. Lancet. 2022. PMID: 35123665 Free PMC article. No abstract available.
COVID-19: An unprecedented challenge and an opportunity for change.
Kwon YJ, Forthal D. Kwon YJ, et al. Adv Drug Deliv Rev. 2021 Apr;171:48-49. doi: 10.1016/j.addr.2021.01.020. Epub 2021 Jan 29. Adv Drug Deliv Rev. 2021. PMID: 33524417 Free PMC article. No abstract available.
COVID-19 and global equity for health: The good, the bad, and the wicked.
Geng EH, Reid MJA, Goosby E, Abdool-Karim Q. Geng EH, et al. PLoS Med. 2021 Oct 1;18(10):e1003797. doi: 10.1371/journal.pmed.1003797. eCollection 2021 Oct. PLoS Med. 2021. PMID: 34597296 Free PMC article. Review.
FDA authorizes Pfizer-BioNTech COVID-19 vaccine.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Jan 11;63(1615):1-2. Med Lett Drugs Ther. 2021. PMID: 33646996 Review. No abstract available.

See all similar articles

Cited by

The impact of COVID-19 on primary health care services in Qatar: 2 years of response and coping 2020-2021.
Al Kuwari MG, Bakri AH, Kandy MC, Gibb JM, Abdulla MY, Al Abdulla SA, Abdulmalik MA. Al Kuwari MG, et al. J Family Med Prim Care. 2022 Dec;11(12):7743-7749. doi: 10.4103/jfmpc.jfmpc_1259_22. Epub 2023 Jan 17. J Family Med Prim Care. 2022. PMID: 36994058 Free PMC article.
Factors Associated with a Lack of Willingness to Vaccinate against COVID-19 in Poland: A 2021 Nationwide Cross-Sectional Survey.
Raciborski F, Samel-Kowalik P, Gujski M, Pinkas J, Arcimowicz M, Jankowski M. Raciborski F, et al. Vaccines (Basel). 2021 Sep 8;9(9):1000. doi: 10.3390/vaccines9091000. Vaccines (Basel). 2021. PMID: 34579237 Free PMC article.
The Multidimensional Vaccine Hesitancy Scale: A Validation Study.
Balgiu BA, Sfeatcu R, Țâncu AMC, Imre M, Petre A, Tribus L. Balgiu BA, et al. Vaccines (Basel). 2022 Oct 20;10(10):1755. doi: 10.3390/vaccines10101755. Vaccines (Basel). 2022. PMID: 36298620 Free PMC article.
Impact of low vaccine coverage on the resurgence of COVID-19 in Central and Eastern Europe.
Fan G, Song H, Yip S, Zhang T, He D. Fan G, et al. One Health. 2022 May 19;14:100402. doi: 10.1016/j.onehlt.2022.100402. eCollection 2022 Jun. One Health. 2022. PMID: 35611185 Free PMC article.
The story behind Chile's rapid rollout of COVID-19 vaccination.
Aguilera X, Mundt AP, Araos R, Weitzel T. Aguilera X, et al. Travel Med Infect Dis. 2021 Jul-Aug;42:102092. doi: 10.1016/j.tmaid.2021.102092. Epub 2021 May 27. Travel Med Infect Dis. 2021. PMID: 34051353 Free PMC article. No abstract available.

See all "Cited by" articles

References

1. WHO WHO Coronavirus (COVID-19) Dashboard. 2021. https://covid19.who.int/
1. European Medicines Agency COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. 2021. https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-...
1. WHO WHO statement on AstraZeneca COVID-19 vaccine safety signals. March 17, 2021. https://www.who.int/news/item/17-03-2021-who-statement-on-astrazeneca-co...
1. Rosen B, Waitzberg R, Israeli A. Israel's rapid rollout of vaccinations for COVID-19. Isr J Health Policy Res. 2021;10:6. - PMC - PubMed
1. Baraniuk C. Covid-19: how the UK vaccine rollout delivered success, so far. BMJ. 2021;372:n421. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information